Pancreatic Delta Cell Neuroendocrine Tumor

Pancreatic Delta Cell Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01465659	Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery	completed	Phase 1 / Phase 2	29	Northwestern UniversityOTHER	1	Aug 5, 2021	clinicaltrials
NCT01010126	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	completed	Phase 2	252	National Cancer Institute (NCI)NIH	2	Jan 25, 2019	clinicaltrials

Data updated 23 days agoSource updated Aug 5, 2021source: clinicaltrials